Keryx Biopharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch KERX and buy or sell other stocks, ETFs, and their options commission-free!

About KERX

Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. 

CEO
Jodie P. Morrison
CEOJodie P. Morrison
Employees
Employees
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1998
Founded1998
Employees
Employees

KERX Key Statistics

Market cap
404.49M
Market cap404.49M
Price-Earnings ratio
-4.41
Price-Earnings ratio-4.41
Dividend yield
Dividend yield
Average volume
2.10M
Average volume2.10M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.98
52 Week high$5.98
52 Week low
$2.47
52 Week low$2.47

Stock Snapshot

Keryx Biopharmaceuticals(KERX) stock is priced at $3.36, giving the company a market capitalization of 404.49M. It carries a P/E multiple of -4.41.

On 2026-01-24, Keryx Biopharmaceuticals(KERX) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 2.1M.

Over the past 52 weeks, Keryx Biopharmaceuticals(KERX) stock has traded between a high of $5.98 and a low of $2.47.

Over the past 52 weeks, Keryx Biopharmaceuticals(KERX) stock has traded between a high of $5.98 and a low of $2.47.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.